Hirofumi Taki

Hirofumi Taki

Auto-generated profile, based on publicly available information

Hirofumi Taki

University of Toyama Faculty of Medicine Academic Assembly Toyama Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
KHKazuya Hirata
Kazuya Hirata
HTHirofumi Taki
Hirofumi Taki
KSKouichiro Shinoda
Kouichiro Shinoda
HHHiroyuki Hounoki
Hiroyuki Hounoki
TMTatsuro Miyahara
Tatsuro Miyahara
ESEiji Sugiyama
Eiji Sugiyama
Whether tumor progression locus 2 (Tpl2)/cancer Osaka thyroid (Cot) protein kinase participates in osteoclastogenesis from receptor activator of nuclear factor-kappaB ligand (RANKL)-stimulated monocytes/macrophages remains elusive. To clarify this, a selective and potent inhibitor of Tpl2, 1,7-naphtyridine-3-carbonitrile, was used. When RAW264.7 cells were stimulated with RANKL, Tpl2 was found to be activated. Under this condition, the Tpl2 inhibitor suppressed osteoclastogenesis in a dose-dependent manner. This was due to the blockade of the phosphorylation of mitogen activated protein kinase/ERK kinase (MEK) and extracellular signal-regulated kinase (ERK), but not c-Jun N-terminal kinase (JNK) or p38, concomitant with the down-regulation of the c-Fos and nuclear factor of activated T cells (NFAT)c1 genes. A long period of RANKL-stimulated cell exposure to the inhibitor suppressed osteoclastogenesis as assessed by tartrate-resistant acid phosphatase (TRAP) staining and pit formation on dentin slices. Almost identical results were obtained with macrophage colony-stimulating factor (M-CSF) and RANKL-stimulated bone marrow cells. These findings suggest the possibility that Tpl2 plays a pivotal role in osteoclastogenesis and thus that its inhibitor is useful for investigating the differentiation of monocytes/macrophages to osteoclasts after treatment with RANKL or other stimuli.

4 July 2020 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
TOTatsuhiko Ozawa
Tatsuhiko Ozawa
KOKazuhisa Ouhara
Kazuhisa Ouhara
RTReina Tsuda
Reina Tsuda
SMSyuichi Munenaga
Syuichi Munenaga
HKHidemi Kurihara
Hidemi Kurihara
HKHiroyuki Kishi
Hiroyuki Kishi

1 November 2015 in European Journal Of Dermatology
Verified
Journal Article
Closed access
PDF file
MMMegumi Mizawa
Megumi Mizawa
TMTeruhiko Makino
Teruhiko Makino
TNTomoko Nakamura
Tomoko Nakamura
SYSatoshi Yamaguchi
Satoshi Yamaguchi
HTHirofumi Taki
Hirofumi Taki
TSTadamichi Shimizu
Tadamichi Shimizu